4 completed, 1 terminated. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Isradipine: new trials by email Literature Review of Isradipine trials Research Report on Isradipine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Improving Buprenorphine Detoxification Outcomes With Isradipine Isradipine, Placebo - Opioid Dependence | Phase 1 / Phase 2 | Completed | University of Arkansas | 28 | 2013-10-01 | 2017-06-05 |
| Adjunctive Isradipine for the Treatment of Bipolar Depression Isradipine, Placebo - Bipolar Disorder | Phase 2 | Terminated | Massachusetts General Hospital | 2 | 2013-02-01 | 2017-04-20 |
| Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients New Medication: Enalapril, Isradipine, Propranolol - Hypertension Secondary to Kidney Transplant | Phase 2 / Phase 3 | Completed | Northwell Health | 33 | 2009-11-01 | 2021-04-13 |
| Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease Isradipine CR 5mg, Isradipine CR 10mg, Isradipine CR 20mg - Parkinson Disease | Phase 2 | Completed | Northwestern University | 99 | 2009-07-01 | 2013-04-17 |
| Parkinson's Disease Isradipine Safety Study Dynacirc CR (Isradipine) - Parkinson's Disease | Phase 2 | Completed | Northwestern University | 31 | 2008-04-01 | 2021-11-15 |
Parkinson Disease (2) · Bipolar Disorder (1) · Depression (1) · Opioid-Related Disorders (1)
Northwestern University (2) · Massachusetts General Hospital (1) · Northwell Health (1) · University of Arkansas (1)
United States (5) · Canada (1)
Alison Oliveto, PhD (1) · Christine B Sethna, MD, EdM (1) · Roy H Perlis, MD, MSc (1) · Tanya Simuni, M.D. (1) · Tanya Simuni, MS (1)
R21DA035325 (1)